Intrinsic Value of S&P & Nasdaq Contact Us

Aditxt, Inc. ADTX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$160.00
+37895.7%

Aditxt, Inc. (ADTX) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.

The consensus price target is $160.00, representing an upside of 37895.7% from the current price $0.42.

Analysts estimate Earnings Per Share (EPS) of $-102,061,600.00 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-216.59 vs est $-102,061,600.00 (beat +100%). 2025: actual $-1,153.83 vs est $-831,408,800.00 (beat +100%). Analyst accuracy: 0%.

ADTX Stock — 12-Month Price Forecast

$160.00
▲ +37,895.73% Upside
Average Price Target
Based on 2 Wall Street analysts offering 12-month price targets for Aditxt, Inc., the price target is $160.00.
The average price target represents a +37,895.73% change from the last price of $0.42.

ADTX Analyst Ratings

Buy
2
Ratings
1 Buy
1 Hold
Based on 2 analysts giving stock ratings to Aditxt, Inc. in the past 3 months
Rating breakdown
Buy
1 50%
Hold
1 50%
50%
Buy
1 analysts
50%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — ADTX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$216.59 vs Est –$102,061,600.00 ▲ 47,121,927.8% off
2025 Actual –$1,153.83 vs Est –$831,408,800.00 ▲ 72,056,338.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — ADTX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.001B ▼ 1,000.9% off
2025 Actual $0.003B vs Est $0.001B ▲ 62.4% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message